The association of BMI with risk of recurrence and progression in patients with non-muscle-invasive bladder cancer
- PMID: 30687600
- PMCID: PMC6323281
- DOI: 10.21037/tau.2018.10.17
The association of BMI with risk of recurrence and progression in patients with non-muscle-invasive bladder cancer
Conflict of interest statement
Conflicts of interest: The author has no conflicts of interest to declare.
Comment on
-
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer.World J Urol. 2019 Mar;37(3):507-514. doi: 10.1007/s00345-018-2397-1. Epub 2018 Jul 10. World J Urol. 2019. PMID: 29992381
Similar articles
-
No clear associations of adult BMI and diabetes mellitus with non-muscle invasive bladder cancer recurrence and progression.PLoS One. 2020 Mar 25;15(3):e0229384. doi: 10.1371/journal.pone.0229384. eCollection 2020. PLoS One. 2020. PMID: 32210471 Free PMC article.
-
Chronic kidney disease as a risk factor for recurrence and progression in patients with primary non-muscle-invasive bladder cancer.Int J Urol. 2017 Aug;24(8):594-600. doi: 10.1111/iju.13389. Epub 2017 Jul 22. Int J Urol. 2017. PMID: 28734027
-
Previous Bladder Cancer History in Patients with High-Risk, Non-muscle-invasive Bladder Cancer Correlates with Recurrence and Progression: Implications of Natural History.Cancer Res Treat. 2015 Jul;47(3):495-500. doi: 10.4143/crt.2014.050. Epub 2014 Sep 11. Cancer Res Treat. 2015. PMID: 25483745 Free PMC article.
-
Non-muscle invasive bladder cancer risk stratification.Indian J Urol. 2015 Oct-Dec;31(4):289-96. doi: 10.4103/0970-1591.166445. Indian J Urol. 2015. PMID: 26604439 Free PMC article. Review.
-
Prediction models for progression of non-muscle-invasive bladder cancer: A review.Int J Urol. 2018 Mar;25(3):212-218. doi: 10.1111/iju.13509. Epub 2017 Dec 16. Int J Urol. 2018. PMID: 29247553 Review.
References
-
- Cambier S, Sylvester RJ, Collette L, et al. EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guerin. Eur Urol 2016;69:60-9. 10.1016/j.eururo.2015.06.045 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources